217 related articles for article (PubMed ID: 31949486)
1. Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases.
Li C; Ma Y; Fei F; Zheng M; Li Z; Zhao Q; Du J; Liu K; Lu R; Zhang S
J Cancer; 2020; 11(4):826-836. PubMed ID: 31949486
[TBL] [Abstract][Full Text] [Related]
2. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
3. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
[TBL] [Abstract][Full Text] [Related]
4. Regulation of S100A10 Gene Expression.
Głowacka A; Bieganowski P; Jurewicz E; Leśniak W; Wilanowski T; Filipek A
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356598
[TBL] [Abstract][Full Text] [Related]
5. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
[TBL] [Abstract][Full Text] [Related]
6. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
Bharadwaj AG; Kempster E; Waisman DM
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
[TBL] [Abstract][Full Text] [Related]
7. S100A10 regulates plasminogen-dependent macrophage invasion.
O'Connell PA; Surette AP; Liwski RS; Svenningsson P; Waisman DM
Blood; 2010 Aug; 116(7):1136-46. PubMed ID: 20424186
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites.
Phipps KD; Surette AP; O'Connell PA; Waisman DM
Cancer Res; 2011 Nov; 71(21):6676-83. PubMed ID: 22042827
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin.
Zhang Y; Zhou ZH; Bugge TH; Wahl LM
J Immunol; 2007 Sep; 179(5):3297-304. PubMed ID: 17709546
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of plasmin generation by S100A10.
Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
[TBL] [Abstract][Full Text] [Related]
11. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.
Madureira PA; O'Connell PA; Surette AP; Miller VA; Waisman DM
J Biomed Biotechnol; 2012; 2012():353687. PubMed ID: 23118506
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of S100A10 expression in cancer.
Tantyo NA; Karyadi AS; Rasman SZ; Salim MRG; Devina A; Sumarpo A
Oncol Lett; 2019 Feb; 17(2):1417-1424. PubMed ID: 30675195
[TBL] [Abstract][Full Text] [Related]
13. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
Noye TM; Lokman NA; Oehler MK; Ricciardelli C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells.
Zhang L; Fogg DK; Waisman DM
J Biol Chem; 2004 Jan; 279(3):2053-62. PubMed ID: 14570893
[TBL] [Abstract][Full Text] [Related]
15. Multiple functions of S100A10, an important cancer promoter.
Saiki Y; Horii A
Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
[TBL] [Abstract][Full Text] [Related]
16. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
Bydoun M; Waisman DM
Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.
Lokman NA; Ho R; Gunasegaran K; Bonner WM; Oehler MK; Ricciardelli C
J Exp Clin Cancer Res; 2019 Jan; 38(1):10. PubMed ID: 30621740
[TBL] [Abstract][Full Text] [Related]
18. Membranous S100A10 involvement in the tumor budding of colorectal cancer during oncogenesis: report of two cases with immunohistochemical analysis.
Arai K; Ishimatsu H; Iwasaki T; Tsuchiya C; Sonoda A; Ohata K
World J Surg Oncol; 2020 Nov; 18(1):289. PubMed ID: 33160379
[TBL] [Abstract][Full Text] [Related]
19. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.
Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N
Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
Zhang J; Guo B; Zhang Y; Cao J; Chen T
Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
